These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 5543710

  • 1. Use of 51Cr in studies on cellular immunity to Mycobacterium tuberculosis, Brucella melitensis and poliovirus, type I.
    Vickrey HM, Elberg SS.
    J Immunol; 1971 Jan; 106(1):191-9. PubMed ID: 5543710
    [No Abstract] [Full Text] [Related]

  • 2. [The effect of radiation-protective agents, cysteine and adrenalin on the distribution of Na2Cr51-04 in the animal organism].
    Grigoresku S, Nedelku K, Néstase M.
    Radiobiologiia; 1967 Jan; 7(1):123-6. PubMed ID: 5608517
    [No Abstract] [Full Text] [Related]

  • 3. [Inborn natural immunity to Brucella melitensis. II. Genetic factors of hereditary immunity to Brucella melitensis in goats].
    León AP, Guerrero J.
    Rev Invest Salud Publica; 1969 Jan; 29(2):107-26. PubMed ID: 5802750
    [No Abstract] [Full Text] [Related]

  • 4. [Studies on the osteotropic properties of radioactive chromium (51Cr). II].
    Wojciechoswki JM.
    Pol Przegl Radiol Med Nukl; 1968 Jan; 32(6):787-96. PubMed ID: 5710809
    [No Abstract] [Full Text] [Related]

  • 5. The effect of anionic, cationic, and nonionic detergents on the percutaneous absorption of sodium chromate (51Cr) in the guinea pig.
    Wahlberg JE.
    Acta Derm Venereol; 1968 Jan; 48(6):549-55. PubMed ID: 4185290
    [No Abstract] [Full Text] [Related]

  • 6. [Studies on the mechanism of binding of radioactive chromium (51Cr) with proteins. II. Binding of radioactive chromium (51Cr) by free aminoacids].
    Kapuściński A.
    Pol Przegl Radiol Med Nukl; 1967 Jan; 31(5):735-45. PubMed ID: 6079195
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Release of chromium 51 by coxsackievirus-infected FL cells].
    Eichhorn U, Klöcking R, Schweizer H, Senf L, Sprössig M.
    Biomed Biochim Acta; 1983 Jan; 42(9):1165-77. PubMed ID: 6671001
    [Abstract] [Full Text] [Related]

  • 13. Qualitative and quantitative studies of cytotoxic immune cells.
    Canty TG, Wunderlich JR, Fletcher F.
    J Immunol; 1971 Jan; 106(1):200-8. PubMed ID: 5101177
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of Brucella melitensis Rev. 1 vaccine against Brucella ovis infection in rams.
    Fensterbank R, Pardon P, Marly J.
    Ann Rech Vet; 1982 Jan; 13(2):185-90. PubMed ID: 7168540
    [Abstract] [Full Text] [Related]

  • 15. 51Cr uptake by erythrocytes. Kinetic studies.
    van Kampen EJ, Reinkingh WA, Heerspink W.
    Clin Chim Acta; 1966 Jan; 13(1):52-60. PubMed ID: 5917684
    [No Abstract] [Full Text] [Related]

  • 16. A note on adult sheep vaccination with reduced dose of Brucella melitensis Rev 1.
    Blasco JM, Estrada A, Mercadal M.
    Ann Rech Vet; 1984 Jan; 15(4):553-6. PubMed ID: 6529126
    [Abstract] [Full Text] [Related]

  • 17. [Immunological properties of a phenol-insoluble extract from Brucella melitensis (P.I. fraction)].
    Roux J, Asselineau J, Serre A, Lacave C.
    Ann Inst Pasteur (Paris); 1967 Sep; 113(3):411-23. PubMed ID: 6048204
    [No Abstract] [Full Text] [Related]

  • 18. Subcellular distribution of 51Cr and characterization of its binding sites in human platelets.
    Steiner M, Baldini M.
    Blood; 1970 May; 35(5):727-39. PubMed ID: 4245914
    [No Abstract] [Full Text] [Related]

  • 19. Dissociation of delayed-type hypersensitivity from acquired murine resistance to Brucella suis.
    Escande A, Cannat A, Serre A.
    Ann Immunol (Paris); 1980 May; 131D(2):199-204. PubMed ID: 7469385
    [Abstract] [Full Text] [Related]

  • 20. Absorption-inhibiting effect of barrier creams.
    Wahlberg JE.
    Berufsdermatosen; 1971 Aug; 19(4):197-207. PubMed ID: 5566606
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.